Exercise in a Bottle
From The Deep Dive · 58:31
Show by FlyingFree
Scientific research highlights the discovery of Lac-Phe, a signaling molecule produced by the body during high-intensity exercise that naturally suppresses appetite and helps manage obesity. Because this hormone is quickly eliminated from the bloodstream, researchers developed ENV-308, a synthetic oral medication designed to replicate these metabolic benefits. Phase 1 clinical trials recently demonstrated that this drug is safe and well-tolerated in humans, notably lacking the gastrointestinal issues often caused by existing weight-loss treatments. The therapy shows significant promise for weight maintenance, potentially helping patients preserve muscle mass and prevent the common "yo-yo" regain of weight after stopping GLP-1 medications. Beyond weight control, these "exercise mimetics" are being investigated for their potential to treat metabolic syndrome, neuroinflammation, and Alzheimer's disease. Together, this describes a transition from understanding the molecular chemistry of physical activity to creating a daily pill that offers exercise-like health protections.
More episodes of The Deep Dive
More episodes
- Tylenol, Pregnancy and Austim: Is There a Link?
- AI-Designed Pathogens and the New Synthetic Biology Arms Race
- Microplastics: Health Hazard or Health Scare?
- Ultra-Processed Foods: Real Threat or Hype?
- Evolution's Civil War: Gene vs Group
- Overthrowing a Scientific Dogma: Clovis First
- Is String Theory Really Science?
- The Younger Dryas Impact Hypothesis
- Prion Diseases: Unstoppable Plagues
- Anti-Aging Science
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.